Two new Wuhan coronavirus variants circulating in California may reduce antibodies produced in response to the pathogen. Their higher reproductive rate has led them to become the dominant variants circulating in the state. The Centers for Disease Control and Prevention has named them a “variant of concern” alongside similar strains found in Great Britain, South Africa and Brazil. Scientists … Continue reading New coronavirus variants in California reduce immune response from vaccines and therapies
FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment
The Food and Drug Administration (FDA) gave Eli Lilly’s antibody drug emergency-use authorization on Monday, Nov. 9. Early data has strongly suggested that the pharmaceutical company’s antibody drug is effective at keeping people with mild to moderate cases of the Wuhan coronavirus (COVID-19) from needing to get admitted to a hospital. The FDA extended the emergency approval to the experimental therapy known … Continue reading FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment
Dr. Eddy Bettermann MD 